News and Media
Keep up to date with Biosero news
Biosero and Analytik Jena Enter Co-marketing Agreement for Automated Liquid Handling Laboratory Workflow
SAN DIEGO, CA & JENA, Germany | February 14, 2023
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Analytik Jena today announced a co-marketing agreement that will allow the companies to promote applications of their combined laboratory automation technologies that will enable customers to accelerate and optimize their scientific research. Biosero and Analytik Jena will be demonstrating these workflows at the SLAS2023 International Conference and Exhibition taking place in San Diego from February 25 to March 1.
Biosero and AltemisLab Collaborate to Streamline Automated Sample Management Workflows
SAN DIEGO, CA & CAMBRIDGE, UK | February 7, 2023
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and AltemisLab, leaders of sample management consumables and equipment to optimize inventory management workflows, today announced a collaboration that will streamline sample management automation for customers. The companies will also be showcasing their joint technology approach at the SLAS2023 International Conference and Exhibition taking place in San Diego from February 25 to March 1.
Biosero and Virscidian Announce Collaboration for Medicinal Chemistry Applications in Drug Discovery
SAN DIEGO, CA & CARY, N.C. | January 31, 2023
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Virscidian, developer of solutions to automate LC/MS (liquid chromatography and mass spectrometry) decision-driven workflows, today announced a collaboration and co-marketing agreement through which the companies will support fully automated analytical workflows for medicinal chemistry as well as other scientific applications, including accelerated screening for drug metabolism and pharmacokinetics (DMPK).
Biosero and DeepCure Collaborate to Establish Fully Automated, AI-Powered Chemistry Synthesis Platform
SAN DIEGO and BOSTON | January 4, 2023
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and DeepCure, a therapeutics company powered by next-generation AI and AI-enabling technologies, today announced their collaboration on an advanced, fully automated chemistry synthesis platform to accelerate drug discovery. The platform, which is part of DeepCure’s Molecular Foundry, based in Rehovot, Israel, will be powered by DeepCure’s innovative AI engine and Biosero’s Green Button Go® suite of laboratory automation software.
Biosero Wins Innovation Award for Product of the Year
SAN DIEGO | July 26, 2022
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, announced that its Acceleration Lab has been named a winner of the 2022 Sales and Marketing Technology Awards from the Business Intelligence Group.
Biosero, a Part of BICO Biosciences, Is Awarded a New Patent for Laboratory Automation Scheduling Software
GOTHENBURG, SWEDEN | May 24, 2022
Granted by the United States Patent and Trademark Office, with extensions filed globally, the patent covers an approach that gives laboratories the ability to increase productivity for time and cost efficiencies.
Biosero Expands Laboratory Automation Capabilities with New Product Launches.
San Diego | FEBRUARY 22, 2022
Biosero, Inc., a BICO company, and a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the launch of several new products and features in the company’s Green Button Go® software suite. Together, these products deliver an array of advanced capabilities to help customers streamline, control, and generate better results from their automated lab systems.
Biosero Joins Genedata Ready-to-Run Program to Streamline Lab Automation and Data Analysis
SAN DIEGO | February 3, 2022
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced that it has joined the Genedata Ready-to-Run program, which helps to accelerate drug discovery with frictionless integrations that streamline laboratory automation processes in biopharmaceutical companies. Through this agreement, customers of both companies will experience more seamless connections between Biosero’s Green Button Go® lab automation software and Genedata Screener®, a platform for bioassay data analysis and management used by the majority of the top 50 biopharma companies worldwide.
Biosero Collaborates with Araceli Biosciences for High-Content Analysis
SAN DIEGO | February 1, 2022
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform into automated workflows controlled by Biosero’s Green Button Go® software suite.
BICO completes the acquisition of Biosero
San Diego | DECEMBER 28, 2021
As announced on December 16, 2021, BICO Group AB (publ) (“BICO”) entered into an agreement to acquire Biosero, Inc (“Biosero”), a leading software provider for automated workflows and laboratory connectivity. BICO has on this day completed the acquisition of all Biosero-shares.
BICO has entered into an agreement to acquire Biosero, a leading software provider for automated workflows and laboratory connectivity
San Diego | DECEMBER 16, 2021
The addition of Biosero’s software capabilities brings immediate synergies and will allow BICO to offer its customers fully automated and connected workflow solutions using the combination of technologies and products from current portfolio companies together with Biosero’s software solutions. In the short to mid-term, these cross-business synergies have the potential to unlock large orders related to automated workflows. BICO will also invest 20 MUSD over a three-year period to further accelerate Biosero’s commercial agenda to expand to new geographical markets and to fully monetize on current order pipeline.
Biosero’s David Dambman Honored with CTO of the Year Award
SAN DIEGO | November 30, 2021
Business Wire – Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced that its Chief Technology Officer David Dambman has been honored by the 2021 Top Tech Awards, recognizing his leadership and ability to solve technical challenges.
Biosero and Bio-Strategy Enter Into ANZ Distribution Agreement
SAN DIEGO and MELBOURNE, Australia | November 16, 2021
Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Bio-Strategy, a leading Australian distributor of equipment and consumables, today announced a distribution agreement to bring Biosero’s Green Button Go® lab automation software and integration solutions to scientists in Australia, New Zealand, and the South Pacific (collectively known as ANZ). The collaboration will give ANZ research institutions and organizations access to cutting-edge automation features to improve performance across life science laboratories.
Biosero’s Tom Gilman Receives CEO of the Year Award
SAN DIEGO | June 24, 2021
Business Wire — Biosero, Inc., developer of automation solutions that enable laboratories to make better decisions in less time using more data, today announced that its founder and CEO Tom Gilman has been named a CEO of the Year by the San Diego Business Journal. The award honors chief executives of companies located in San Diego County for achievements within their companies and in the community.
Can robots speed up drug discovery? San Diego firm's software helps labs embrace automation
San Diego | June 11, 2021
At Biosero’s Sorrento Mesa headquarters, a mobile robot named Yoda wheels down the hallway to personally escort visitors to the company’s Acceleration Lab. Then Yoda gets to work — picking up and delivering biological assay trays between scanning instruments scattered throughout the lab in a demonstration of how the Biosero’s technology helps speed up drug discovery through automation.
Biosero Appoints Ryan Bernhardt as Chief Commercial Officer
SAN DIEGO | May 11, 2021
Biosero, Inc., developer of automation solutions that enable laboratories to make better decisions in less time using more data, today announced two key hires as it expands commercial operations. Ryan Bernhardt joins the company as Chief Commercial Officer, and Ruth Petersen is named Director of Marketing.
Celltrio and Biosero Automated Solutions Accelerate Cell Culture and Harvesting Process 2-3 Fold
SAN DIEGO and SANTA CLARA, CA | March 3, 2021
Biosero, Inc. and Celltrio, Inc. will integrate Biosero’s Green Button Go™ Automation Scheduling Software with Celltrio’s innovative RoboCell™ Automation Platform to accelerate cell line culturing and harvesting processes, including cryogenic storage, into a highly flexible and modular end-to-end system.
Life Science Labs Produce Accurate and Reliable Data with Biosero and Elemental Machines Integrated Technologies
SAN DIEGO, CA & CAMBRIDGE, MA | December 7, 2020
Biosero, Inc. and Elemental Machines will integrate Biosero’s Green Button Go™ Automation Scheduling Software with Elemental Machines’ AI-powered platform so scientists and researchers can produce consistent, reliable results from every life science laboratory experiment.
TetraScience and Biosero Pair Autonomous Robotic Workcells with R&D Cloud Data
SAN DIEGO, CA & BOSTON, MA | November 17, 2020
Biosero, Inc. and TetraScience, Inc. announced they will integrate data glyphs, instruments and robotic sensors with the cloud-native Tetra Data Platform using Green Button Go™ Automation Scheduling Software. Together the systems will automatically collect, store and harmonize life science R&D data in the cloud to accelerate drug discovery and research.
Biosero Webinar: Integrating Laboratory Automation Software for Data-Driven Decision Making
SAN DIEGO | August 25th, 2020
Biosero concludes its “Automate Your Lab with Software for Data Decisions” webinar series with an inside look at how laboratory automation software enables pharmaceutical manufacturers to make complex decisions in less time while upholding quality assurance and data tracking.
RORZE Lifescience partners with Biosero to commercialize Green Button Go automation scheduling software in Japan, China
SAN DIEGO | December 3, 2019
Biosero, Inc. announced a new partnership wherein RORZE Lifescience, Inc., a subsidiary of Rorze, Inc. (TYO: 6323), will commercialize Biosero’s Green Button Go™ Automation Scheduling Software in Asia. RORZE Lifescience, Inc. (RLS) will adopt Green Button Go as its exclusive automation scheduling software and distribute it to customers in the clinical, pharmaceutical, research and biotech sectors in Japan and via its joint venture with Rorze ReMed Lifescience Co., Ltd. in China.